Harbin Pharmaceutical Group Holding Co., Ltd.

4 articles about Harbin Pharmaceutical Group Holding Co., Ltd.

• ECMOHO Limited and Harbin Pharmaceutical Group Announce Joint Launch of New Iron Supplement Product

  5/17/2021

  ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the health and wellness market in China, announced today that on May 10, 2021, a new product, Puxue Oral Liquid, which is a supplement intended for use by children aged between one and 17, adults, pregnant women, and nursing mothers who suffer from iron and vitamin B12 deficiencies, is jointly launched by the Company and Harbin Pharmaceutical

• 111 Signs Strategic Cooperation with Harbin Pharmaceutical Group

  7/24/2019

  The agreement will enable both companies to serve customers by providing access to high-quality products and services.

• Harbin Pharma to Acquire 40% of US-based GNC for $300M

  2/14/2018

  Hayao will also form a JV with GNC to make and distribute GNC supplements in China.

• Harbin Pharmaceutical Group Holding Co., Ltd. Trades $870 Million of Stock for Assets from Parent

  1/3/2012